Your browser is no longer supported. Please, upgrade your browser.
Quantum-Si incorporated
Index- P/E- EPS (ttm)-0.25 Insider Own16.40% Shs Outstand11.70M Perf Week0.23%
Market Cap1.21B Forward P/E- EPS next Y- Insider Trans0.00% Shs Float- Perf Month2.95%
Income-3.60M PEG- EPS next Q- Inst Own41.30% Short Float- Perf Quarter-27.09%
Sales- P/S- EPS this Y- Inst Trans17.15% Short Ratio4.31 Perf Half Y-17.97%
Book/sh43.09 P/B0.20 EPS next Y- ROA-1.70% Target Price- Perf Year-
Cash/sh3.76 P/C2.32 EPS next 5Y- ROE-1.80% 52W Range7.43 - 25.00 Perf YTD-14.09%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-66.28% Beta-
Dividend %- Quick Ratio66.60 Sales past 5Y- Gross Margin- 52W Low13.46% ATR0.45
Employees112 Current Ratio66.60 Sales Q/Q- Oper. Margin- RSI (14)46.81 Volatility5.71% 5.43%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.44 Prev Close8.72
ShortableYes LT Debt/Eq0.00 EarningsAug 16 AMC Payout- Avg Volume1.13M Price8.43
Recom- SMA20-1.36% SMA50-3.54% SMA200-20.58% Volume487,194 Change-3.33%
Oct-20-21Initiated Canaccord Genuity Buy $13
Oct-19-21 04:15PM  
Sep-21-21 04:15PM  
Sep-13-21 11:26AM  
Aug-16-21 04:05PM  
Aug-11-21 07:00AM  
Jul-27-21 08:30AM  
Jun-24-21 04:05PM  
Quantum-Si incorporated operates first next-generation protein sequencing and genomics platform for healthcare industries. It offers a single molecule detection solution to decode the molecules of life, including sample preparation, single molecule, massively parallel, and protein identification. The company's technology has the applications in proteomics, single cell, transcriptomics, genomics, metabolomics, and drug testing and screening fields. The company is based in Guilford, Connecticut. Quantum-Si incorporated is a subsidiary of 4Catalyzer Corporation.